Search results - A new view of care

4 Kenvue clinical studies that helped us earn trust with science

Over the past four years, our scientists have conducted more than 500 clinical studies, all of which help to deliver safe, effective, everyday care at every stage of life.

November 11, 2024

Tylenol® commits $1 million to support injured athletes over next three years

September 17, 2024

Female gymnast in red leotard shown in multiple stages of landing and falling after a vault

Eczema, psoriasis and dermatitis: Understanding common skin conditions

While all three conditions can leave your skin red, irritated and uncomfortable, do you know the differences between them?

October 28, 2024

Doctor looking at patients skin in doctor office

Kenvue publishes clinical evidence showing nicotine mouth spray is effective for relief of vaping cravings

September 25, 2024

By the numbers: How Kenvue’s Healthy Lives Mission is making an impact

Our Healthy Lives Mission environmental, social and governance strategy outlines 20 goals and commitments to hold us accountable for demonstrating progress.

November 18, 2024

Johnson & Johnson appoints Thibaut Mongon as CEO Designate of planned new consumer health company

The company has also appointed Paul Ruh as CFO Designate. Mongon and Ruh to assume new leadership roles upon the completion of the planned separation of the consumer health business. Planned separation expected to occur in 2023.

May 11, 2022

Johnson & Johnson appoints Larry Merlo as Non-Executive Chair Designate of new consumer health company

Former President and CEO of CVS Health, Merlo will assume board leadership role with the new consumer health company and support preparations for the planned separation, expected to occur in 2023

August 24, 2022

Connecting care across the world through our global reach

Learn about Kenvue in your area

Argentina

Brazil

Central America

Chile

Colombia

Germany

India

Japan

Mexico

United Kingdom